These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15023165)

  • 41. Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia.
    Ford AC; Moayyedi P; Black CJ; Yuan Y; Veettil SK; Mahadeva S; Kengkla K; Chaiyakunapruk N; Lee YY
    Aliment Pharmacol Ther; 2021 Jan; 53(1):8-21. PubMed ID: 32936964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials.
    Dobrilla G; Comberlato M; Steele A; Vallaperta P
    J Clin Gastroenterol; 1989 Apr; 11(2):169-77. PubMed ID: 2567747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The controlled single subject trial.
    Johannessen T; Petersen H; Kristensen P; Fosstvedt D
    Scand J Prim Health Care; 1991 Mar; 9(1):17-21. PubMed ID: 1675018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Functional Dyspepsia.
    Delgado-Aros S; Cremonini F; Talley NJ
    Curr Treat Options Gastroenterol; 2004 Apr; 7(2):121-131. PubMed ID: 15010026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H2-blocking drugs for dyspepsia.
    Tomlinson MJ
    Lancet; 1994 May; 343(8908):1302. PubMed ID: 7910315
    [No Abstract]   [Full Text] [Related]  

  • 46. Trials are not for the benefit of patients.
    Kapitein P
    Ann Transl Med; 2016 Jan; 4(1):22. PubMed ID: 26855958
    [No Abstract]   [Full Text] [Related]  

  • 47. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunopathological and molecular basis of functional dyspepsia and current therapeutic approaches.
    Addula M; Wilson VED; Reddymasu S; Agrawal DK
    Expert Rev Clin Immunol; 2018 Oct; 14(10):831-840. PubMed ID: 30235962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Search for unpublished data by systematic reviewers: an audit.
    Ziai H; Zhang R; Chan AW; Persaud N
    BMJ Open; 2017 Oct; 7(10):e017737. PubMed ID: 28988181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections.
    Naber KG; Niggemann H; Stein G; Stein G
    BMC Infect Dis; 2014 Nov; 14():628. PubMed ID: 25427651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional dyspepsia today.
    Voiosu TA; Giurcan R; Voiosu AM; Voiosu MR
    Maedica (Bucur); 2013 Mar; 8(1):68-74. PubMed ID: 24023602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Helicobacter pylori infection in functional dyspepsia.
    Suzuki H; Moayyedi P
    Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):168-74. PubMed ID: 23358394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].
    Gisbert JP; Calvet X; Ferrándiz J; Mascort J; Alonso-Coello P; Marzo M; ; ;
    Aten Primaria; 2012 Dec; 44(12):727.e1-727.e38. PubMed ID: 23036729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD?
    Looijer-van Langen M; Veldhuyzen van Zanten S
    Open Med; 2007; 1(3):e181-3. PubMed ID: 21673950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review.
    Stuber K; Sajko S; Kristmanson K
    J Can Chiropr Assoc; 2011 Mar; 55(1):47-55. PubMed ID: 21403782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Managing dyspepsia.
    Ford AC; Moayyedi P
    Curr Gastroenterol Rep; 2009 Aug; 11(4):288-94. PubMed ID: 19615304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton pump inhibitors: effective first-line treatment for management of dyspepsia.
    Peura DA; Gudmundson J; Siepman N; Pilmer BL; Freston J
    Dig Dis Sci; 2007 Apr; 52(4):983-7. PubMed ID: 17342402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification.
    Suzuki H; Nishizawa T; Hibi T
    J Gastroenterol; 2006 Jun; 41(6):513-23. PubMed ID: 16868798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.